Status:
RECRUITING
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
Lead Sponsor:
Philip Morris Products S.A.
Conditions:
COPD
Smoking
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symptoms (e.g., cough frequency, shortness of breath, a...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
April 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
290 Patients enrolled
Trial Details
Trial ID
NCT07108166
Start Date
April 2 2025
End Date
November 1 2026
Last Update
September 12 2025
Active Locations (111)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research of West Florida, Inc.
Clearwater, Florida, United States, 33765
2
Florida International Medical Research
Coral Gables, Florida, United States, 33134
3
Alfa Medical Research
Davie, Florida, United States, 33024
4
Omega Research Debary, LLC
DeBary, Florida, United States, 32713